BMI and lipid levels in Mexican American children diagnosed with type 2 diabetes

Worldviews on Evidence-Based Nursing

Volumn 5, Issue 3, 2008, Pages 142-147

  Fortmeier Saucier, Linda ^a,b   Savrin, Carol ^a   Heinzer, Marjorie ^a   Hudak, Christine ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Child; Lipids; Mexican; Obesity; Type 2 diabetes mellitus

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; BODY MASS; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; HISPANIC; HUMAN; LIPID BLOOD LEVEL; MEDICAL CARE; MEDICAL RECORD REVIEW; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY;

ADOLESCENT; ADULT; BODY MASS INDEX; CHILD; COMORBIDITY; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERLIPIDEMIAS; LIPIDS; LOGISTIC MODELS; MEXICAN AMERICANS; MEXICO; OBESITY; RETROSPECTIVE STUDIES; SOUTHWESTERN UNITED STATES;

EID: 51749115976     PISSN: 1545102X     EISSN: 17416787     Source Type: Journal    
DOI: 10.1111/j.1741-6787.2008.00122.x     Document Type: Article

References (32)

1. Agarwal S. & Marshall G. (1998). Glucocorticoid-induced type 1/type 2 cytokine alterations in humans: A model for stress-related immune dysfunction. Interferon Cytokine, 18, 1059 1068.
2. American Academy of Pediatrics 1998). Cholesterol in childhood. Pediatrics, 101 (1 141 147.
3. American Diabetes Association 1998). Economic consequences of diabetes mellitus in the United States. Diabetes Care, 21, 296 309.
4. American Diabetes Association 2003). Clinical practice recommendations. Diabetes Care, 26, 33 50.
5. Anavian J., Brenner D.J., Fort P. & Speiser P.W. (2001). Profiles of obese children presenting for metabolic evaluation. Pediatric Endocrinology Metabolism, 14 (8 1145 1150.
6. Bao W., Srinivasan S.R., & Berenson G.S. (1996). Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults: The Bogalusa heart study. Circulation, 93 (1 54 59.
7. Bao W., Srinivasan S.R., Valdez R., Greenlund K.J., Wattigney W.A. & Berenson G.S. (1997). Longitudinal changes in cardiovascular risk from childhood to young adulthood in offspring of parents with coronary artery disease: The Bogalusa heart study. JAMA, 278 (21 1749 1754.
8. Barlow S.E., Dietz W.H., Klish W.J. & Trowbridge F.L. (2002). Medical evaluation of overweight children and adolescents: Reports from pediatricians, pediatric nurse practitioners, and registered dietitians. Pediatrics, 110 (1 222 228.
9. Batey L.S., Goff D.C., Tortolero S.R., Nichaman M., Chan W., Chan F., Grunbaum J., Hanls L. & Labarthe D 1997). Summary measures of the insulin resistance syndrome are adverse among Mexican-American versus non-Hispanic White children. Circulation, 96, 4619 4325.
10. Berenson G.S., Srinivasan S.R., Bao W., Newman W.P., Tracy R.E. & Wattigney W.A. (1998). Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The New England Journal of Medicine, 338 (23 1650 1656.
11. Black P. & Garbutt L. (2002). Stress, inflammation and cardiovascular disease. Journal of Psychosomatic Research, 52, 1 23.
12. Centers for Disease Control 2004). CDC table for calculated body mass index values for selected heights and weights for ages 2 to 20. Retrieved October 1, 2004, http://medscape.com/viewprogram/2640_pnt.
13. Chen Y.D., Bao W., Begum S., Elkasabany A., Srinivasan S. & Berenson G.S. (2000). Age-related patterns of the clustering of cardiovascular risk variables of syndrome X from childhood to young adulthood in a population made up of black and white subjects: The Bogalusa heart study. Diabetes, 49 (6 1042 1048.
14. Chrousos G. & Gold P. (1998). A healthy body in a healthy mind and vice versa the damaging power of uncontrollable stress. Journal of Clinical Endocrinology Metabolism, 83, 1842 1845.
15. Glowinska B., Urban M., Koput A. & Galar M. (2003). New atheroscierosis risk factors in obese, hypertensive and diabetic children and adolescents. Atheroscierosis, 167 (2 275 286.
16. Goran M.I., Geoff D., Ball C. & Cruz M. (2003). Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents. The Journal of Clinical Endocrinology & Metabolism, 88 (4 1417 1427.
17. Haffner S., Stern M.P., Mitchell B.D., Hazuda H.P. & Patterson J.K. (1990). Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution. Diabetes, 39 (3 283 288.
18. Haffner S., Miettinen H., Gaskill S. & Stern M. (1995). Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican Americans. Diabetes, 44, 1386 1391.
19. Howdle S. & Wilkin T. (2001). Type 2 diabetes in children. Diabetes Care, 15 (18) 38 42.
20. Jiang X., Srinivasan S.R., Webber L.S., Wattigney W.A. & Berenson G.S. (1995). Association of fasting insulin level with serum lipid and lipoprotein levels in children, adolescents, and young adults: The Bogalusa heart study. Archives of Internal Medicine, 155 (2 190 196.
21. Mitchell B.D., Renhart L.J., Kammerer C.M. & Stern M.P. (1994). NIDDM in Mexican American families: Heterogeneity by age of onset. Diabetes Care, 17, 567 573.
22. Mokdad A.H., Ford E.S., Bowman B.A., Nelson D.E., Engelgau M.M., Vinicor F. & Marks J.S. (2000). Diabetes trends in the US: 1990-1998. Diabetes Care, 23, 1278 1283.
23. Plourde G. (2002). Impact of obesity on glucose and lipid profiles in adolescents at different age groups in relation to adulthood. BMC Family Practice, 3 (18 21 39.
24. Rosmond R. (2004). Role of stress in the pathogenesis of the metabolic syndrome. Psychoneuroendocrinology, 30, 1 10.
25. Scott L. (2006). Insulin resistance syndrome in children. Retrieved June 1, 2007, from http://medscape.com/viewprogram/534035_print.
26. Selye H. (1946). The general adaptation syndrome and the diseases of adaptation. Journal of Clinical Endocrinology, 6, 117 130.
27. Shea S., Aymong E., Zybert P., Shamoon H., Tracy R., Deckelbaum R. & Basch C 2003). Obesity, fasting plasma insulin, and C-reactive protein levels in healthy children. Obesity Research, 11 (1 95 103.
28. Steinberger J. & Daniels S.R. (2003). Obesity, insulin resistance, diabetes, and cardiovascular risk in children. Circulation, 107, 1448 1159.
29. Ursin H. & Eriksen H. (2003). The cognitive activation theory of stress. Psychoneuroendocrinology, 29, 567 592.
30. U.S. Department of Health and Human Services 2000). Tracking healthy people 2010. Retrieved December 2, 2004, from http://www.healthypeople.gov/ publications.
31. Winkleby M., Robinson T., Sundquist J. & Kraemer H. (1999). Ethnic variation in cardiovascular disease risk factors among children and young adults. JAMA, 281 (11 1006 1013.
32. Yusuf S., Gerstein H., Hoogwerf B., Pogue J., Bosch J., Wolffenbuttel B.H. & Zinman B. (2001). HOPE study investigators: Ramipril and the development of diabetes. JAMA, 286, 1882 1885.